000			01914 a2200505 4500
005			20250517174139.0
264		0	_c20180705
008			201807s 0 0 eng d
022			_a1879-0712
024	7		_a10.1016/j.ejphar.2017.09.023 _2doi
040			_aNLM _beng _cNLM
100	1		_aLi, Qi
245	0	0	_a20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription. _h[electronic resource]
260			_bEuropean journal of pharmacology _cNov 2017
300			_a173-180 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aCarcinoma, Hepatocellular _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCyclin-Dependent Kinase Inhibitor p15 _xgenetics
650	0	4	_aCyclin-Dependent Kinase Inhibitor p16 _xgenetics
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aEnhancer of Zeste Homolog 2 Protein _xmetabolism
650	0	4	_aG1 Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aGinsenosides _xpharmacology
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aMultigene Family _xgenetics
650	0	4	_aPromoter Regions, Genetic _xgenetics
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aResting Phase, Cell Cycle _xdrug effects
650	0	4	_aTranscription, Genetic _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aLi, Bai
700	1		_aDong, Chengya
700	1		_aWang, Yajie
700	1		_aLi, Qi
773	0		_tEuropean journal of pharmacology _gvol. 815 _gp. 173-180
856	4	0	_uhttps://doi.org/10.1016/j.ejphar.2017.09.023 _zAvailable from publisher's website
999			_c27582617 _d27582617